Tag: FDA Section 505A

Pediatric Exclusivity: How the FDA Extends Market Protection for Drugs

By Joe Barnett    On 28 Nov, 2025    Comments (14)

blog-post-image

Pediatric exclusivity gives drugmakers six extra months of market protection after completing FDA-requested studies in children. It doesn't extend patents but blocks generic approval, even after patent expiration, ensuring safer pediatric dosing.

View More

Categories

Recent Post

recent-post-image Vaccinations While on Immunosuppressants: Live vs Inactivated Guidance
recent-post-image Ketotifen vs. Other Allergy Treatments: Full Comparison Guide
recent-post-image How to Safely Buy Online Cheap Generic Ciprofloxacin - A Practical Guide
recent-post-image Isosorbide Mononitrate: A Personal Journey of Managing Angina
recent-post-image Foreign Manufacturing Quality Issues: How Overseas Production Risks Are Rising in 2026

Menu

© 2026. All rights reserved.